SEC Filing Summary: Tuscan Holdings Corp. (10-K)
Business Context and Reporting Period
This Form 10-K covers the period from the company's inception on November 5, 2018, through December 31, 2018. Tuscan Holdings Corp. is a blank check company (Special Purpose Acquisition Company or SPAC) incorporated in Delaware. The company was formed solely to effectuate a merger, share exchange, asset acquisition, or similar business combination with one or more target businesses, with a current focus on the cannabis industry. As of the reporting date, the company had not commenced any operations and had generated no revenue.
Key Financial Metrics
The financial data below reflects the company's status as of December 31, 2018, prior to the consummation of its Initial Public Offering (IPO) in March 2019.
| Metric | Value |
|---|---|
| Revenue | $0 (No operations) |
| Net Loss | $(792) |
| Cash and Cash Equivalents | $17,500 |
| Total Assets | $101,200 (Includes $83,675 in deferred offering costs) |
| Total Liabilities | $75,792 (Includes $75,342 promissory note to related party) |
| Stockholders' Equity | $25,408 |
| Shares Outstanding | 7,200,000 (Includes 6,900,000 Founder Shares and 300,000 Representative Shares) |
Note: The filing details a subsequent IPO consummated on March 7, 2019, which raised gross proceeds of $240 million, plus an additional $36 million from an over-allotment exercise on March 12, 2019. A total of $276 million was placed in a trust account following these transactions.
Material Changes and Subsequent Events
The most significant material change occurred after the reporting period ended. While the company held only $17,500 in cash as of December 31, 2018, it successfully completed its IPO in March 2019. Key subsequent events include:
- IPO Completion: Sold 24,000,000 units at $10.00 per unit, generating $240 million in gross proceeds.
- Over-Allotment: Underwriters exercised the full over-allotment option, selling an additional 3,600,000 units for $36 million.
- Private Placement: Sold 687,000 Private Units (615,000 initially + 72,000 with over-allotment) to the Sponsor and underwriter designees for approximately $6.87 million.
- Trust Account: $276 million was deposited into a trust account to fund the future business combination.
- Working Capital: Approximately $809,840 was held outside the trust account for working capital purposes.
Outlook, Risks, and Management Commentary
Outlook and Strategy: The company intends to use the funds in the trust account to acquire a target business with a fair market value of at least 80% of the trust assets. The company has until December 7, 2020, to complete a business combination. If no combination is completed by this date, the company will liquidate and distribute the trust funds to public shareholders.
Risks and Contingencies:
- Liquidation Risk: If the company fails to complete a business combination within the specified timeframe, it must liquidate, and warrants will expire worthless.
- Redemption Risk: Public shareholders have the right to redeem their shares upon the completion of a business combination, which could reduce the cash available for the transaction.
- Working Capital Deficiency: The company may need to obtain additional financing to complete a business combination or cover operating expenses if funds outside the trust are insufficient.
- Related Party Transactions: The company pays an affiliate of the CEO $10,000 per month for administrative support. Insiders may also provide working capital loans, up to $1.5 million of which may be convertible into units.
Management Commentary: Management emphasizes that the company is an "emerging growth company" and has not generated operating revenues. The primary focus is on identifying and evaluating target businesses in the cannabis sector.
Investor Verification Checklist
- Trust Account Status: Verify the current balance and interest earnings in the $276 million trust account.
- Target Identification: Confirm if a target business has been identified and the status of any merger agreements.
- Redemption Rights: Review the specific terms under which public shareholders can redeem shares and the potential impact on deal financing.
- Related Party Fees: Monitor the $10,000 monthly administrative fee and any additional working capital loans from insiders.
- Warrant Terms: Understand the exercise price ($11.50) and redemption conditions for the public warrants.
- Liquidation Deadline: Note the December 7, 2020, deadline for completing a business combination.